Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
European Journal of Cancer Care
|
July 9, 2020
Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
David Roder, Sudarsha Selva-Nayagam, Sellvakumaran Paramasivam, et al.
Medicine
|
January 15, 2016
Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy
Zhihuang Hu, Wenhua Liang, Yunpeng Yang, et al.
BMC Cancer
|
August 30, 2019
Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
Ming Li, Ian Olver, Dorothy Keefe, et al.
Cancer
|
April 27, 2004
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
Edward B Rubenstein, Douglas E Peterson, Mark Schubert, et al.
BMJ Open
|
February 21, 2019
Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum
David Roder, Margaret Davy, Sid Selva-Nayagam, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 1, 2015
Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades
David Roder, Christos S Karapetis, David Wattchow, et al.
The Lancet. Oncology
|
March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
Christina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2018
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model
Kate R Secombe, Imogen A Ball, Joseph Shirren, et al.
Cancer
|
April 27, 2004
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients
Stephen T Sonis, Linda S Elting, Dorothy Keefe, et al.
Journal of Evaluation in Clinical Practice
|
September 23, 2016
Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation
David Roder, Gelareh Farshid, Grantley Gill, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
European Journal of Cancer Care
|
July 9, 2020
Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
David Roder, Sudarsha Selva-Nayagam, Sellvakumaran Paramasivam, et al.
Medicine
|
January 15, 2016
Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy
Zhihuang Hu, Wenhua Liang, Yunpeng Yang, et al.
BMC Cancer
|
August 30, 2019
Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
Ming Li, Ian Olver, Dorothy Keefe, et al.
Cancer
|
April 27, 2004
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
Edward B Rubenstein, Douglas E Peterson, Mark Schubert, et al.
BMJ Open
|
February 21, 2019
Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum
David Roder, Margaret Davy, Sid Selva-Nayagam, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 1, 2015
Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades
David Roder, Christos S Karapetis, David Wattchow, et al.
The Lancet. Oncology
|
March 9, 2016
Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial
Christina H Ruhlmann, Thomas Broe Christensen, Line Hammer Dohn, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2018
Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model
Kate R Secombe, Imogen A Ball, Joseph Shirren, et al.
Cancer
|
April 27, 2004
Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients
Stephen T Sonis, Linda S Elting, Dorothy Keefe, et al.
Journal of Evaluation in Clinical Practice
|
September 23, 2016
Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation
David Roder, Gelareh Farshid, Grantley Gill, et al.
Page
of 6